14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jun 14, 2023 Buy 39 875 Vink Patrick V.j.j. Stock Option
Jun 14, 2023 Buy 39 875 Srivastava Sapna Stock Option
Jun 14, 2023 Buy 39 875 Schulman Amy W Stock Option
Jun 14, 2023 Buy 39 875 Schegerin Marc Common Stock
Jun 14, 2023 Buy 39 875 Jensen Klavs F. Stock Option
Jun 14, 2023 Buy 39 875 Garg Pushkal Stock Option
Jun 14, 2023 Buy 39 875 Elia Marc Stock Option
Jun 14, 2023 Buy 39 875 Coulie Bernard Stock Option
Jun 14, 2023 Buy 39 875 Bolno Paul Stock Option
Jan 24, 2023 Buy 213 000 Capasso Richard Stock Option
Jan 24, 2023 Buy 261 000 Warren Marshelle Smith Stock Option
Jan 24, 2023 Buy 227 000 Knopf Lawrence J Stock Option
Jan 24, 2023 Buy 200 000 First David Stock Option
Jan 24, 2023 Buy 830 000 Bernstein Howard Phd Md Stock Option
Aug 15, 2022 Sell 1 183 Capasso Richard Common Stock
Jul 11, 2022 Buy 10 000 Zajic Micah Stock Option
Jun 30, 2022 Buy 2 436 Sharei Armon Common Stock
Jun 30, 2022 Buy 1 484 Knopf Lawrence J Common Stock
Jun 30, 2022 Buy 1 183 Capasso Richard Common Stock
Jun 15, 2022 Buy 20 000 Schulman Amy W Stock Option
Jun 15, 2022 Buy 20 000 Garg Pushkal Stock Option
Jun 15, 2022 Buy 20 000 Bolno Paul Stock Option
Jun 15, 2022 Buy 20 000 Bolno Paul Stock Option
Jun 15, 2022 Buy 20 000 Vink Patrick V.j.j. Stock Option
Jun 15, 2022 Buy 20 000 Srivastava Sapna Stock Option
Jun 15, 2022 Buy 20 000 Jensen Klavs F. Stock Option
Jun 15, 2022 Buy 20 000 Schegerin Marc Stock Option
Jun 15, 2022 Buy 20 000 Coulie Bernard Stock Option
Jun 15, 2022 Buy 20 000 Coulie Bernard Stock Option
Jun 15, 2022 Buy 20 000 Elia Marc Stock Option
Jun 01, 2022 Buy 200 000 Warren Marshelle Smith Stock Option
Jun 01, 2022 Buy 0 Warren Marshelle Smith
May 25, 2022 Buy 14 326 Jensen Klavs F. Common Stock
Feb 10, 2022 Buy 66 000 First David Stock Option
Feb 10, 2022 Buy 80 000 Zajic Micah Stock Option
Feb 10, 2022 Buy 42 000 Capasso Richard Stock Option
Feb 10, 2022 Buy 395 000 Sharei Armon Stock Option
Feb 10, 2022 Buy 97 000 Knopf Lawrence J Stock Option
Feb 10, 2022 Buy 195 000 Bernstein Howard Phd Md Stock Option
Jan 12, 2022 Buy 13 000 Sharei Armon Common Stock
Jan 12, 2022 Sell 13 000 Sharei Armon Stock Option
Dec 31, 2021 Buy 1 686 Sharei Armon Common Stock
Dec 31, 2021 Buy 454 Knopf Lawrence J Common Stock
Dec 22, 2021 Buy 6 581 Schulman Amy W Common Stock
Dec 22, 2021 Buy 7 458 Schulman Amy W Common Stock
Dec 22, 2021 Buy 10 091 Schulman Amy W Common Stock
Dec 22, 2021 Sell 6 581 Schulman Amy W Stock Option
Dec 22, 2021 Sell 7 458 Schulman Amy W Stock Option
Dec 22, 2021 Sell 10 091 Schulman Amy W Stock Option
Dec 22, 2021 Buy 11 049 Sharei Armon Common Stock
Dec 22, 2021 Sell 11 049 Sharei Armon Stock Option
Dec 13, 2021 Buy 1 850 Schulman Amy W Common Stock
Dec 13, 2021 Buy 1 850 Schulman Amy W Common Stock
Nov 11, 2021 Buy 37 000 Capasso Richard Stock Option
Jul 01, 2021 Buy 21 000 Vink Patrick V.j.j. Stock Option
Jul 01, 2021 Buy 21 000 Coulie Bernard Stock Option
Jul 01, 2021 Buy 0 Vink Patrick V.j.j.
Jul 01, 2021 Buy 0 Coulie Bernard
Jun 15, 2021 Buy 10 500 Elia Marc Stock Option
Jun 15, 2021 Buy 10 500 Schegerin Marc Stock Option
Jun 15, 2021 Buy 10 500 Schulman Amy W Stock Option
Jun 15, 2021 Buy 10 500 Garg Pushkal Stock Option
Jun 15, 2021 Buy 10 500 Srivastava Sapna Stock Option
Jun 15, 2021 Buy 10 500 Jensen Klavs F. Stock Option
Jun 15, 2021 Buy 10 500 Bolno Paul Stock Option
Feb 27, 2021 Buy 8 000 Sharei Armon Common Stock
Feb 27, 2021 Sell 8 000 Sharei Armon Stock Option (Right to Buy)
Feb 23, 2021 Buy 48 100 Knopf Lawrence J Stock Option
Feb 23, 2021 Buy 22 339 Zajic Micah Stock Option
Feb 23, 2021 Buy 75 625 Rosen Oliver Stock Option
Feb 23, 2021 Buy 28 900 First David Stock Option
Feb 23, 2021 Buy 72 900 Bernstein Howard Phd Md Stock Option
Feb 23, 2021 Buy 75 950 Loxam Teri Stock Option
Feb 23, 2021 Buy 195 000 Sharei Armon Stock Option (Right to Buy)
Jan 08, 2021 Buy 2 500 Sharei Armon Common Stock
Jan 08, 2021 Sell 2 500 Sharei Armon Stock Option (Right to Buy)
Nov 03, 2020 Buy 625 000 Temasek Holdings (private) Ltd Common Stock
Nov 03, 2020 Buy 1 888 924 Temasek Holdings (private) Ltd Common Stock
Nov 03, 2020 Sell 1 888 924 Temasek Holdings (private) Ltd Series D Preferred Stock
Nov 03, 2020 Buy 1 511 139 American International Group Inc Common Stock
Nov 03, 2020 Buy 625 000 American International Group Inc Common Stock
Nov 03, 2020 Buy 70 344 American International Group Inc Common Stock
Nov 03, 2020 Buy 38 895 American International Group Inc Common Stock
Nov 03, 2020 Sell 66 803 American International Group Inc Series C Preferred Stock
Nov 03, 2020 Sell 36 937 American International Group Inc Series D Preferred Stock
Nov 03, 2020 Buy 14 662 Jensen Klavs F. Common Stock
Nov 03, 2020 Sell 6 908 Jensen Klavs F. Series B Convertible Preferred Stock
Nov 03, 2020 Sell 7 017 Jensen Klavs F. Series Seed Convertible Preferred Stock
Nov 03, 2020 Buy 233 654 Polaris Management Co. Vii, L.l.c. Common Stock
Nov 03, 2020 Buy 233 654 Schulman Amy W Common Stock
Nov 03, 2020 Buy 2 315 652 Schulman Amy W Common Stock
Nov 03, 2020 Buy 2 315 652 Polaris Management Co. Vii, L.l.c. Common Stock
Nov 03, 2020 Buy 275 860 Schulman Amy W Common Stock
Nov 03, 2020 Buy 22 204 Schulman Amy W Common Stock
Nov 03, 2020 Buy 16 346 Schulman Amy W Common Stock
Nov 03, 2020 Buy 16 346 Polaris Management Co. Vii, L.l.c. Common Stock
Nov 03, 2020 Buy 161 994 Polaris Management Co. Vii, L.l.c. Common Stock
Nov 03, 2020 Buy 161 994 Schulman Amy W Common Stock
Nov 03, 2020 Sell 93 279 Schulman Amy W Series D Convertible Preferred Stock
Oct 29, 2020 Buy 32 643 Zajic Micah Stock Option
INSIDER POWER
56.145
Last 100 transactions
Buy: 14 710 100 | Sell: 2 159 730 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 56.145.

In total, the insiders bought 14 710 100 and sold 2 159 730 SQZ shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Sqz Biotechnologies Company

Sqz Biotechnologies Company SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, incl... SQZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT